Bayer World Investments B.V.'s Net Worth

$9.46 Million

Estimate Recalculated Nov 7, 2024 04:56PM EST

Who is World Investments B.V. Bayer

World Investments B.V. Bayer has an estimated net worth of $9.46 Million. This is based on reported shares across multiple companies, which include Azitra Inc, Elanco Animal Health Inc, Century Therapeutics, Inc., Pyxis Oncology, Inc., Senti Biosciences, Inc., and Metagenomi, Inc..

SEC CIK

World Investments B.V. Bayer's CIK is 0001820027

Past Insider Trading and Trends

2021 was World Investments B.V. Bayer's most active year for acquiring shares with 1 total transactions. World Investments B.V. Bayer's most active month to acquire stocks was the month of September. 2021 was World Investments B.V. Bayer's most active year for disposing of shares, totalling 2 transactions. World Investments B.V. Bayer's most active month to dispose stocks was the month of September. 2021 saw World Investments B.V. Bayer paying a total of $0.00 for 2,742,338 shares, this is the most they've acquired in one year. In 2021 World Investments B.V. Bayer cashed out on 17,438,534 shares for a total of $0.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Azitra Inc

Investor
Updated Jul 24, 2023
Form 4
Jul 24, 2023
1.31M
Options
Jun 21
Form 3
Jul 24, 2023
Showing 2 results

Elanco Animal Health Inc

Investor
Updated Dec 03, 2020
Form 4
-74.71%
-54.50M
$29.84
-$1.63B
Dec 03, 2020
18.45M
Sale
Dec 03
Form 3
Aug 03, 2020
72.95M
Showing 2 results

Century Therapeutics, Inc.

Investor
Updated Jun 23, 2021
Form 4
-57.76%
-17.33M
$20.00
Jun 23, 2021
12.68M
Buy-Options
Jun 22
Form 3
Jun 17, 2021
Showing 2 results

Pyxis Oncology, Inc.

Investor
Updated Oct 15, 2021
Form 4
-84.27%
-14.70M
Oct 15, 2021
2.74M
Options
Oct 13
Form 3
Oct 07, 2021
Showing 2 results

Senti Biosciences, Inc.

Investor
Updated Feb 13, 2023
Form 3
Feb 13, 2023
5.88M
Showing 1 results

Metagenomi, Inc.

Investor
Updated Feb 15, 2024
Form 4
-42.76%
-3.03M
Feb 15, 2024
4.05M
Options
Feb 13
Form 3
Feb 15, 2024
Showing 2 results